T. Cerny

553 total citations
23 papers, 406 citations indexed

About

T. Cerny is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, T. Cerny has authored 23 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in T. Cerny's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). T. Cerny is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). T. Cerny collaborates with scholars based in Switzerland, Germany and United Kingdom. T. Cerny's co-authors include M. Bacchi, K. Buser, R Joss, Christoph Hürny, A. von Rohr, Martin F. Fey, U Hess, Jürg Bernhard, Daniel Betticher and H. J. Altermatt and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

T. Cerny

23 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Cerny Switzerland 15 131 103 88 71 71 23 406
Alexandra Rubin United States 12 73 0.6× 106 1.0× 50 0.6× 118 1.7× 50 0.7× 37 536
I J Lewis United Kingdom 14 142 1.1× 45 0.4× 38 0.4× 92 1.3× 103 1.5× 23 545
Maho Sato Japan 13 141 1.1× 48 0.5× 63 0.7× 78 1.1× 61 0.9× 49 510
Stella Bowcock United Kingdom 13 116 0.9× 98 1.0× 159 1.8× 102 1.4× 27 0.4× 43 727
Ruth Dworsky United States 15 222 1.7× 233 2.3× 75 0.9× 29 0.4× 47 0.7× 21 547
R. E. Davis Australia 10 58 0.4× 49 0.5× 37 0.4× 61 0.9× 19 0.3× 19 336
Gürses Şahin Türkiye 12 69 0.5× 84 0.8× 20 0.2× 87 1.2× 31 0.4× 45 372
Tianyou Wang China 13 85 0.6× 35 0.3× 36 0.4× 94 1.3× 25 0.4× 62 468
Caterina Mancusi Italy 12 113 0.9× 74 0.7× 13 0.1× 111 1.6× 58 0.8× 22 520
Shelly Sharma United States 9 101 0.8× 36 0.3× 46 0.5× 217 3.1× 69 1.0× 34 531

Countries citing papers authored by T. Cerny

Since Specialization
Citations

This map shows the geographic impact of T. Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Cerny more than expected).

Fields of papers citing papers by T. Cerny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Cerny. The network helps show where T. Cerny may publish in the future.

Co-authorship network of co-authors of T. Cerny

This figure shows the co-authorship network connecting the top 25 collaborators of T. Cerny. A scholar is included among the top collaborators of T. Cerny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Cerny. T. Cerny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strasser, Florian, Rolf Oberholzer, David Blum, et al.. (2011). Lenalidomide in solid tumor patients with inflammatory cancer cachexia: A multicenter, randomized, double-blind, proof-of-concept study of fixed dose or CRP-response-guided dose or placebo.. Journal of Clinical Oncology. 29(15_suppl). TPS239–TPS239. 1 indexed citations
2.
Morant, R., Jürg Bernhard, D. Dietrich, et al.. (2004). Capecitabine in hormone-resistant metastatic prostatic carcinoma – a phase II trial. British Journal of Cancer. 90(7). 1312–1317. 29 indexed citations
3.
Hitz, Felicitas, et al.. (2003). Acute Pericarditis and Pleural Effusion Complicating Cytarabine Chemotherapy. Oncology Research and Treatment. 26(4). 348–350. 16 indexed citations
4.
Helbig, Horst, T. Cerny, & Marc D. de Smet. (2003). Intravitreale Chemotherapie bei okulozerebralem Lymphom. Der Ophthalmologe. 100(2). 145–149. 15 indexed citations
5.
Rohr, A. von, S.‐F. Hsu Schmitz, André Tichelli, et al.. (2002). Treatment of hairy cell leukemia with cladribine(2-chlorodeoxyadenosine) by subcutaneous bolus injection:a phase II study. Annals of Oncology. 13(10). 1641–1649. 37 indexed citations
6.
Buetler, Timo M., O.H.G. Wilder‐Smith, Clive H. Wilder‐Smith, et al.. (2000). Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers. British Journal of Anaesthesia. 84(1). 97–99. 28 indexed citations
7.
Pampallona, S., et al.. (2000). Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer.. PubMed. 130(34). 1173–84. 14 indexed citations
8.
Reinhart, Walter H., Gabriela M. Baerlocher, T. Cerny, et al.. (1999). Ifosfamide‐induced stomatocytosis and mesna‐induced echinocytosis: influence on biorheological properties of blood. European Journal Of Haematology. 62(4). 223–230. 19 indexed citations
9.
Pfister, Marc, Bruno Gottstein, T. Cerny, & Andreas Cerny. (1999). Immunodiagnosis of echinococcosis in cancer patients. Clinical Microbiology and Infection. 5(11). 693–697. 15 indexed citations
10.
Cogliatti, Sergio, U Schmid, Андреас Каппелер, et al.. (1999). T-Cell-Rich B-Cell Non-Hodgkin's Lymphoma Mimicking Hodgkin's Disease. Leukemia & lymphoma. 33(3-4). 393–398. 9 indexed citations
11.
Betticher, Daniel, A. von Rohr, Daniel Ratschiller, et al.. (1998). Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 16(3). 850–858. 23 indexed citations
12.
Bacchi, M., Peter Heusser, Jürg Bernhard, et al.. (1998). The cognitive-spiritual dimension – an important addition to the assessment of quality of life: Validation of a questionnaire (SELT-M) in patients with advanced cancer. Annals of Oncology. 9(10). 1091–1096. 28 indexed citations
13.
Laeng, Hubert, et al.. (1998). Primary cervical malignant teratoma with a rib metastasis in an adult: Five-year survival after surgery and chemotherapy. Annals of Oncology. 9(9). 1015–1022. 11 indexed citations
14.
15.
Betticher, Daniel, Emanuele Zucca, A. von Rohr, et al.. (1996). 2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III–IV non-Hodgkin's lymphoma. Annals of Oncology. 7(8). 793–799. 17 indexed citations
16.
17.
Joss, R, M. Bacchi, Christoph Hürny, et al.. (1995). Early versus late alternating chemotherapy in small-cell lung cancer. Annals of Oncology. 6(2). 157–166. 16 indexed citations
18.
Cerny, T., Martin F. Fey, Rolf Oppliger, et al.. (1992). Prevalence of the rhesus‐negative phenotype in caucasian patients with small‐cell lung cancer (SCLC). International Journal of Cancer. 52(3). 504–506. 18 indexed citations
19.
Cerny, T., et al.. (1990). Bioavailability of subcutaneous Ifosfamide and feasibility of continuous outpatient application in cancer patients. Annals of Oncology. 1(5). 365–368. 8 indexed citations
20.
Joss, R, et al.. (1990). The symptomatic control of cytostatic drug-induced emesis. A recent history and review.. PubMed. 26 Suppl 1. S2–8. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra Rubin Breakdown of academic impact, for papers by I J Lewis Breakdown of academic impact, for papers by Maho Sato Breakdown of academic impact, for papers by Stella Bowcock Breakdown of academic impact, for papers by Ruth Dworsky Breakdown of academic impact, for papers by R. E. Davis Breakdown of academic impact, for papers by Gürses Şahin Breakdown of academic impact, for papers by Tianyou Wang Breakdown of academic impact, for papers by Caterina Mancusi Breakdown of academic impact, for papers by Shelly Sharma
Rankless by CCL
2026